Publications by authors named "Muhammad I Obaid"
Article Synopsis
- The study investigated the link between cancer risks and the use of SGLT2 inhibitors in patients with Type 2 diabetes by following established research guidelines and analyzing data from 19 randomized controlled trials (RCTs).
- The findings indicated a potential increase in certain types of cancers, including reproductive and skin cancers, associated with SGLT2i use, but these results were not statistically significant.
- The study calls for caution regarding SGLT2i prescriptions for diabetic patients and emphasizes the need for further research to better understand the cancer risk connections.
Evaluating the efficacy and safety of weekly Insulin Icodec vs. Daily Insulin Glargine in type 2 Diabetes Mellitus: a systematic review and meta-analysis.
Varisha Zuhair Muhammad Adil Obaid Muhammad Saqlain Mustafa Muhammad Ashir Shafique Burhanuddin Sohail Rangwala Muhammad Ishtiaq Obaid
J Diabetes Metab Disord
June 2024
Introduction: Various insulin therapies for Diabetes Mellitus offer different benefits while having potential risks. We aim to compare Insulin Icodec, a novel Insulin analogue with the ease of once-weekly administration, to the once-daily Insulin Glargine U100 regarding glycemic control and safety profile.
Methods: We performed a systematic literature search of electronic databases for peer-reviewed articles from inception until September 1 2023.
Gastro-esophageal reflux disease (GERD) is a growing health concern. In this cross-sectional study, participants' knowledge, attitude and practice toward GERD were assessed using a questionnaire. In our study of 411 participants, 92.
View Article and Find Full Text PDF